Elaine Sullivan

Elaine Sullivan 0340

Board member

Elected to the Board in 2024 (Board Observer from 2023) and regarded as an independent board member.

  • Member of the Scientific Committee

Special competencies

More than 25 years of experience in the pharmaceutical and biotech industry in senior executive positions, science, investment, business development, and start-ups. Served at AstraZeneca and Eli Lilly and Company as a member of the senior global R&D management teams. 

Current positions

Member of the board of Nykode Therapeutics ASA, IP Group plc, and hVIVO Ltd; member of the supervisory board of Evotec AG.

Share profile